Mapi to establish $13m manufacturing plant for Copaxone generic 30-Jul-2019 By Vassia Barba Mapi to turn a facility previously owned by J&J into a manufacturing plant for the production of GA Depot, a long-acting generic of Teva’s Copaxone.
UPDATED Teva dealt double Copaxone blow amid sales slowdown 15-Oct-2018 By Ben Hargreaves Teva's appeal to protect Copaxone's patents fell through and competitor product, Gilenya, received strong comparative data in the same week.